FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921584080> ?p ?o ?g. }

• W2921584080 endingPage "47" @default.
• W2921584080 startingPage "SCI" @default.
• W2921584080 abstract "Abstract Alternative splicing is employed by all eukaryotic cells to increase proteome diversity and to regulate gene expression. RNA sequencing analysis of purified populations of erythroblasts at different stages of maturation has led to the identification of a dynamic alternative splicing program that directly modulates the protein isoform expression of cytoskeletal proteins and genes involved in RNA processing, heme biosynthesis, and iron transport. Regulated interactions of multiple RNA-binding proteins and cis-regulatory sequences located within exons or their flanking introns promote or inhibit functional spliceosome assembly at splice junctions, leading to altered exon inclusion or intron retention. Exon skipping regulates tissue and stage specific isoform expression of red cell membrane cytoskeletal proteins including EPB41, ankyrin, and band 3. Intron retention can lead to a frame shift during translation and introduction of a premature termination codon (PTC), that marks the transcript for degradation via the nonsense mediated decay pathway (NMD) upon export from the nucleus into the cytoplasm. Intron retention leading to posttranscriptional regulation of gene expression during terminal erythroid maturation has been identified in genes involved in RNA processing and iron transport including SF3B1, SNRNP70, SLC25A37 and SLC25A28. Mutations that alter mRNA splice sites or introduce PTCs lead to a variety of congenital anemias including beta thalassemia, hereditary pyropoikilocytosis, hereditary elliptocytosis, and hereditary spherocytosis. Aberrant mRNA splicing has subsequently been shown to lead to acquired anemias in subsets of patients with myelodysplastic syndromes (MDS). Somatic missense mutations in components of the spliceosome are the most common category of mutations in MDS. These point mutations lead to changes in the RNA binding specificity of the involved proteins and aberrant splicing of a subset of transcripts. Mutant SF3B1, the most commonly mutated splicing factor in MDS, has been shown to cause aberrant pre-mRNA splicing and an increase in transcripts predicted to undergo NMD due to use of upstream, cryptic 3' splice sites. Our group and others evaluating the strong genotype-phenotype association between SF3B1 point mutations and subtypes of MDS with ring sideroblasts have shown that the expression of the mitochondrial iron transporter, ABCB7, is decreased in samples from SF3B1-mutant MDS patients due to cryptic 3' splice site selection and introduction of a PTC between exons 8 and 9. The identification and functional validation of additional aberrantly spliced mutant-SF3B1 target genes is ongoing, with the goal of understanding how point mutations in a core component of the mRNA splicing machinery can lead to such specific effects on erythroid maturation. Disclosures No relevant conflicts of interest to declare." @default.
• W2921584080 created "2019-03-22" @default.
• W2921584080 creator A5088194956 @default.
• W2921584080 date "2018-11-29" @default.
• W2921584080 modified "2023-10-01" @default.
• W2921584080 title "Splicing Control in Normal and Aberrant Erythropoiesis" @default.
• W2921584080 doi "https://doi.org/10.1182/blood-2018-99-109414" @default.
• W2921584080 hasPublicationYear "2018" @default.
• W2921584080 type Work @default.
• W2921584080 sameAs 2921584080 @default.
• W2921584080 citedByCount "0" @default.
• W2921584080 crossrefType "journal-article" @default.
• W2921584080 hasAuthorship W2921584080A5088194956 @default.
• W2921584080 hasBestOaLocation W29215840801 @default.
• W2921584080 hasConcept C104317684 @default.
• W2921584080 hasConcept C166342232 @default.
• W2921584080 hasConcept C194583182 @default.
• W2921584080 hasConcept C2778776201 @default.
• W2921584080 hasConcept C36823959 @default.
• W2921584080 hasConcept C40000846 @default.
• W2921584080 hasConcept C41282012 @default.
• W2921584080 hasConcept C54355233 @default.
• W2921584080 hasConcept C54458228 @default.
• W2921584080 hasConcept C67705224 @default.
• W2921584080 hasConcept C86803240 @default.
• W2921584080 hasConcept C94671646 @default.
• W2921584080 hasConcept C95444343 @default.
• W2921584080 hasConceptScore W2921584080C104317684 @default.
• W2921584080 hasConceptScore W2921584080C166342232 @default.
• W2921584080 hasConceptScore W2921584080C194583182 @default.
• W2921584080 hasConceptScore W2921584080C2778776201 @default.
• W2921584080 hasConceptScore W2921584080C36823959 @default.
• W2921584080 hasConceptScore W2921584080C40000846 @default.
• W2921584080 hasConceptScore W2921584080C41282012 @default.
• W2921584080 hasConceptScore W2921584080C54355233 @default.
• W2921584080 hasConceptScore W2921584080C54458228 @default.
• W2921584080 hasConceptScore W2921584080C67705224 @default.
• W2921584080 hasConceptScore W2921584080C86803240 @default.
• W2921584080 hasConceptScore W2921584080C94671646 @default.
• W2921584080 hasConceptScore W2921584080C95444343 @default.
• W2921584080 hasIssue "Supplement 1" @default.
• W2921584080 hasLocation W29215840801 @default.
• W2921584080 hasOpenAccess W2921584080 @default.
• W2921584080 hasPrimaryLocation W29215840801 @default.
• W2921584080 hasRelatedWork W2041768452 @default.
• W2921584080 hasRelatedWork W2080505162 @default.
• W2921584080 hasRelatedWork W2082142998 @default.
• W2921584080 hasRelatedWork W2463093367 @default.
• W2921584080 hasRelatedWork W2469948286 @default.
• W2921584080 hasRelatedWork W2528442309 @default.
• W2921584080 hasRelatedWork W3084320038 @default.
• W2921584080 hasRelatedWork W3110942791 @default.
• W2921584080 hasRelatedWork W3148733822 @default.
• W2921584080 hasRelatedWork W4200277849 @default.
• W2921584080 hasVolume "132" @default.
• W2921584080 isParatext "false" @default.
• W2921584080 isRetracted "false" @default.
• W2921584080 magId "2921584080" @default.
• W2921584080 workType "article" @default.